- MRNA -0.28%
Pfizer and Moderna Covid-19 vaccines usage and updated safety labels
Yahoo Finance · 14 hours ago
Open | 87.89 |
High | 88.78 |
Low | 86.24 |
Mkt Cap | 33.2B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 86.62 |
52 Wk. Low | 62.55 |
52 Wk. High | 170.47 |
Related stocks
American biotechnology company
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 241M | 29.90% ▼ |
Net Income | -1.28B | - |
Diluted EPS | -3.33 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | -$1.68 | - |
Q2 2024 | -$3.38 | -$3.33 |
Q1 2024 | -$3.58 | -$3.07 |
S&P 500^GSPC | 5,551.78+8.56 (+0.15%) |
Dow 30^DJI | 40,658.99+95.93 (+0.24%) |
Nasdaq^IXIC | 17,622.47+27.97 (+0.16%) |
6.84+17.39% | |
32.13+2.91% | |
Cingulate Inc.CING | 19.49+306.04% |